Skip to main content

Table 1 Clinical features, treatments and prognosis in four cases of MEITL

From: Multiple lesions of gastrointestinal tract invasion by monomorphic epitheliotropic intestinal T-cell lymphoma, accompanied by duodenal and intestinal enteropathy-like lesions and microscopic lymphocytic proctocolitis: a case series

  Case 1 Case 2 Case 3 Case 4
Age (years) 60 40 50 70
Sex M F F M
Chief complaints Diarrhea Diarrhea Abdominal distention Nausea
Duration of chief complains (mons) 17 3 1 2
Total protein (g/dl) 4 4.4 6.6 6.4
Albumin (g/dl) 2.1 2.9 3.8 3
LDH (IU/l) 165 156 187 150
sIL2R (U/ml) 963 1419 4150 587
Anti-gliadin/-transglutaminase tests −/− ne ne ne
Helicobacter pylori IgG antibody ne +
Gastrointestinal perforation + (after treatment)
Bone marrow tumour invasion + (30 %) + (30 %) + (20 %)
Clinical stage IV I IV IV
Treatment (regimen) CHASE, SCT THP-COP, surgery CHOP, SCT SMILE
Response Partial response No response Partial response Partial response
Survival times (months) 36, dead 12, dead 9, dead 9, dead
  1. CHASE Cyclophosphamide, cytarabine, etoposide, dexametahsone, SCT Stem cell transplantation, THP-COP Pirarubicin, cyclophosphamide, vincristine, prednisolone, CHOP Cyclophosphamide, doxorubicin, vincristine, prednisolone, SMILE Dexamethasone, methotrexate, ifosfamide, L-asparaginase, etoposide; ne not examined